Financial LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes Shared by Ken Dropiewski on March 4, 2024 More in Financial: RenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common Stock February 11, 2025 Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025 February 11, 2025 Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront February 10, 2025 This post was originally published on this site Share this story Facebook Twitter LinkedIn LONDON–(BUSINESS WIRE)– #cardiacsurgery–LivaNova PLC announced its intention to offer $300 million aggregate principal amount of convertible senior notes due 2029 in a private offering.